Rivastigmin-Mepha Patch 4.6 mg/24 h

Rivastigmin-Mepha Patch 4.6 mg/24 h is a medicine authorised by Swissmedic under authorisation number 68795. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 November 2022 and the authorisation is limited until 14 November 2027. ATC code N06DA03 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 68795
  • ATC N06DA03
  • Synthetic medicines
Authorisation data
Authorisation number68795
NameRivastigmin-Mepha Patch 4.6 mg/24 h
Full nameRivastigmin-Mepha Patch 4.6 mg/24 h, Transdermale Pflaster
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06DA03
First authorisation15 November 2022
Authorisation validity14 November 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Rivastigmin-Mepha Patch 4.6 mg/24 h, Transdermale PflasterB15 November 2022
2Rivastigmin-Mepha Patch 9.5 mg/24 h, Transdermale PflasterB15 November 2022
3Rivastigmin-Mepha Patch 13.3 mg/24 h, Transdermale PflasterB15 November 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130PflasterN06DA0301.99.0.B
230PflasterN06DA0301.99.0.B
32 x 30PflasterN06DA0301.99.0.B
430PflasterN06DA0301.99.0.B
52 x 30PflasterN06DA0301.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivastigmin-Mepha Patch 4.6 mg/24 h authorised in Switzerland?

Yes. Rivastigmin-Mepha Patch 4.6 mg/24 h is authorised by Swissmedic under authorisation number 68795, data as of 01 September 2026. The authorisation is limited until 14 November 2027.

Which dispensing category does Rivastigmin-Mepha Patch 4.6 mg/24 h have?

Rivastigmin-Mepha Patch 4.6 mg/24 h is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivastigmin-Mepha Patch 4.6 mg/24 h?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com